COVID-19 vaccine trials: The potential for “hybrid” analyses
COVID-19 백신 시험: "하이브리드" 분석의 가능성
Article
[키워드] active comparator
Adenovirus
adenovirus vaccine
aggregate
analysis
Analysis
application
approach
clinical setting
clinical settings
clinical testing
clinical trial
control vaccine
COVID-19
COVID-19 vaccine
duration of follow-up
effective
effective vaccine
Effective vaccines
Efficacy
Efficiency
ENhance
estimate
Evidence
facilitate
Follow-up
Immunity
International
interpretability
margin
mass vaccination
mRNA vaccines
non-inferiority
non-inferiority trial
performed
Placebo
placebo-controlled
placebo-controlled randomized trial
placebo-controlled trial
Randomized
randomized clinical trial
randomized clinical trials
reducing
Region
reliability
risk
Safe
SARS-CoV-2
SARS-CoV-2 infections
scalability
strain
symptomatic disease
Trial
vaccination
Vaccine
vaccine efficacy
Vaccines
Vaccines.
variant
[DOI] 10.1177/17407745211018613 PMC 바로가기 [Article Type] Article
[DOI] 10.1177/17407745211018613 PMC 바로가기 [Article Type] Article